Uncategorised - European Medical Journal

The first edition of AMJ Dermatology is here!

In anticipation for our upcoming launch in the US, say hello to the debut edition of our first ever American Dermatology Journal – out now.

Review of the 2024 American Academy of Dermatology (AAD) Annual Meeting

In the sunny, coastal city of San Diego, California, USA, the American Academy of Dermatology (AAD) hosted the 2024 AAD Annual Meeting…

Effects of Dermal Fillers on Vaginal Laxity and Female Sexual Function: A Minimally Invasive Procedure for Vaginal Rejuvenation

Female health has become one of the most discussed issues today. Many problems, like uterine prolapse, birth injuries, incontinence…

JAK Inhibitors: A New Frontier

JAK INHIBITORS (JAKi) “have changed dermatology, and will continue to change dermatology in ways that no other class of drugs has, or…

Modern Approaches in Psoriasis

A COMPELLING session covered updates on the therapeutic pipeline and role for early treatment of psoriasis at the American Academy of…

Roundtable: How can pharma close the gender health gap?

Robyn Widenmaier (GSK) and Tabetha Sundin (AstraZeneca) discuss whether bids to improve gender parity could be the ticket to change in women’s health.

New Cancer Diagnoses Projected to Reach 35 Million in 2050

Emerging global statistics have revealed that by 2050, there are projected to be 35 million new cases of cancer reported, according to a recent report from the American Cancer Society.

Impact of Fertility Concerns on Breast Cancer Treatment Decisions

According to new research, one-third of females with breast cancer have reported fertility concerns influencing their treatment decisions, with one-fifth discussing fertility preservation strategies with their physician.

Transepidermal Water Loss Predicts Allergic Reaction Severity

New research presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting reveals a potential link between transepidermal water loss (TEWL) and the severity of peanut allergy reactions.

Does Benzodiazepine Use in Pregnancy Increase Miscarriage Risk?

A recent study finds the use of benzodiazepine during pregnancy is linked to a 70% increased risk of miscarriage, urging caution in prescribing for pregnant women. Read more.